SOCS-1, an inflammation suppressor, normally functions as a negative modulator of NF-κB signaling pathways and has been shown to play essential roles in acute liver injury, cardiac injury and AKI (Bai and Chen, 2023; Ma et al., 2013). Here, SOCS1 is linked to acute kidney injury.